FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1007-1008 September 23, 1999 Number 13 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by M.W.E. Morgan, R. Warren, and G. Querci della Rovere. 288 pp., illustrated. London, Harwood Academic, 1998. $95. ISBN 90-5702-469-1.

Since the 1960s, screening for breast cancer by mammography has been the subject of a number of controlled trials. These studies showed that, among 45-to-64-year-old women, regular mammography was associated with a 30 percent decrease in mortality due to breast cancer. A large tumor with high-grade histologic features and lymph-node metastases are associated with a poor prognosis. Mammographic screening can detect small tumors with low-grade histologic patterns that have not spread to the lymph nodes — all features of a good prognosis.

In 1987, the National Health Service Breast Screening Programme (NHSBSP) was founded in the United Kingdom with the . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.